Business · 22/06/1999Updated: 10/17/2026 · 1 min read
FDA's Dermatologic and Ophthalmic Drugs Advisory Committee to Meet on March 15, 2023, to Discuss New Eye Drops
Summary
The FDA's Dermatologic and Ophthalmic Drugs Advisory Committee will convene on March 15, 2023, to review a new proposal for eye drops, as part of its ongoing efforts to ensure the safety and efficacy of ophthalmic medications.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →